Results 91 to 100 of about 239,501 (262)
Background Transforming growth factor (TGF)-β is known to be produced by progressor tumors and to immobilize dendritic cells (DCs) within those tumors.
Imai Kazuhiro +8 more
doaj +1 more source
This bioinspired acinus‐on‐a‐chip recapitulates VILI pathology, revealing that volutrauma drives P53/NF‐κB pathways while barotrauma triggers mitochondrial‐Wnt dysregulation. A fibrotic transitional cell cluster was identified. Pharmacological interventions targeting these pathways significantly ameliorated injury, establishing a mechanobiological ...
Heng Lu +10 more
wiley +1 more source
This study identifies MZF1 as a core regulator of colon cancer via SnoN‐mediated TGF‐β suppression, proposes 10Panx Acetate as a targeted inhibitor, and validates MZF1/SnoN as prognostic markers for aggressive disease. ABSTRACT Colon cancer progression is associated with transcriptional and signaling abnormalities.
Siqi Sheng +9 more
wiley +1 more source
The mRNA levels changes of TGF-β1, Col I, and Col III after TLP treatment.
The groups were designed as Cell-Lv-TLP (HSFs transfected with recombinant lentivirus), Cell-Lv (HSFs transfected with control lentivirus ), Cell (HSFs without any treatment), Cell-Lv-TLP+TGF-β1 (HSFs transfected with recombinant lentivirus and ...
Chen Wang (88408) +6 more
core +1 more source
SLC8A1 deficiency in colorectal cancer cells increases intracellular calcium signaling, promoting the secretion of ANXA2‐enriched small extracellular vesicles. These vesicles reprogram tumor‐associated macrophages towards an M2 phenotype, which in turn fosters a tumor microenvironment conducive to radioresistance and is associated with poor patient ...
Yimin Fang +18 more
wiley +1 more source
Blood Indoxyl Sulfate and TGF-β1 Protein and mRNA Levels in Chronic Kidney Disease: Updated Insights
Chronic kidney disease (CKD) is characterized by systemic inflammation and the accumulation of uremic toxins such as indoxyl sulfate (IS), which induces fibrogenic signaling via transforming growth factor-beta 1 (TGF-β1).
Farhad Nazarinasi +3 more
doaj +1 more source
TIMP-1-GPI impacts TGF-β1 expression and processing.
TGF-β1 can inhibit mesothelial cell migration and proliferation. MMP-9 and MMP-2 can proteolytically activate latent TGF-β1. Cell surface engineering with TIMP-1-GPI leads to a reduction in the expression and processing of latent TGF-β1 to its active ...
Elfriede Noessner (146689) +10 more
core +1 more source
An enzyme–nitric oxide (NO) co‐regulatory strategy reprograms pathological extracellular matrix (ECM)–fibroblast crosstalk in hypertrophic scars. Enzymatic degradation of pre‐existing ECM relieves aberrant mechanical cues, while NO‐mediated fibroblast phenotypic modulation restrains excessive collagen synthesis.
Junzhe Fu +7 more
wiley +1 more source
TGF-β1 induced IGFBP7 expression in HRPTECs.
HRPTECs were incubated for 48 h with the indicated concentrations of TGF-β1 in serum-free medium. IGFBP7 mRNA expression was determined by real-time RT-PCR (A). The expression of IGFBP7 was normalized to that of GAPDH in the same cell extracts.
Masakazu Haneda (343591) +6 more
core +1 more source
SerpinA3 acts as an endogenous TGF‐β receptor antagonist that binds to the extracellular domain of TGFR‐1, thereby preventing TGFR‐1–TGFR‐2 complex formation. This receptor‐level blockade suppresses TGF‐β/Smad2/3 signaling, attenuates cardiac fibroblast activation, and extracellular matrix deposition, and ultimately alleviates pressure overload–induced
Hui Wang +9 more
wiley +1 more source

